Automation hiPSC culture

Automation of several core services - including the mass generation of ‘healthy’ and ‘diseased’ human induced Pluripotent StemCells (hiPSCs). Lines generated from diseased donors will be genetically modified to remove disease mutations. LUMC intends to enter into a Purchase Agreement for the acquisition of a system designed for hiPSC culture automation. The LUMC wishes to achieve the following objectives with this tender and the Agreement stemming from it: a) The purchase of an automated platform for culturing human induced pluripotent stem cells (hiPSCs) after genetic modification; b) A supplier that can deliver all desired components and integrate the system - and is our single point of contact for maintenance and support; c) A platform that focuses on the tasks of cloning and...